LABORATORY NEWS
-
NeoGenomics Introduces PanTracer Pro To Support Timely, Informed Solid Tumor Therapy Selection
NeoGenomics, Inc. a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the availability of PanTracer Pro, a new addition to the PanTracer Family, designed to help clinicians navigate increasingly complex molecular testing workflows to make informed decisions for patients with advanced-stage solid tumors.
- WHOOP Launches Advanced Labs In The UAE With Diagnostic Partner Unilabs, Delivering A Comprehensive View Of Health For Members
- Bracco And ACIST Medical Systems Announce European Launch Of ACIST Pro™ Diagnostic System
- New Blood Test Helps GPs Manage Brain Scan Delays, Brings Field Forward
- Leica Biosystems Revolutionizes Histology Workflows With Global Launch Of The Leica CM1950 Cryostat With DualEcoTec Cooling System
ARCHIVED NEWSLETTER
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- 01.20.26 -- Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving?
- 01.06.26 -- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- 12.23.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- 12.09.25 -- What You Should Know About USP's Bioassay Updates